Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria
McGready, R., Stepniewska, K., Edstein, M. D., Cho, T., Gilveray, G., Looareesuwan, S., White, N. J., & Nosten, F. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0652-9 · Cited by 138
Self-citationMcGready, R., Stepniewska, K., Lindegardh, N., Ashley, E. A., La, Y., Singhasivanon, P., White, N. J., & Nosten, F. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0199-7 · Cited by 115
Self-citationMcGready, R., Cho, T., Samuel, Villegas, L., Brockman, A., van Vugt, M., Looareesuwan, S., White, N. J., & Nosten, F. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90106-3 · Cited by 114
Self-citationMcGready, R., Ashley, E. A., Moo, E., Cho, T., Barends, M., Hutagalung, R., Looareesuwan, S., White, N. J., & Nosten, F. (2005) · The Journal of Infectious Diseases · doi:10.1086/432551 · Cited by 112
Self-citationMcGready, R., Stepniewska, K., Ward, S. A., Cho, T., Gilveray, G., Looareesuwan, S., White, N. J., & Nosten, F. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0118-y · Cited by 101
Self-citationMcGready, R., Keo, N. K., Villegas, L., White, N. J., Looareesuwan, S., & Nosten, F. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)80040-8 · Cited by 64
Self-citation
Research works printed but not linked: 56
- Tagbor, 2006, Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial, Lancet, 368, 1349, 10.1016/S0140-6736(06)69559-7 · DOI · Paper page
- Okoyeh, 1993, Sensitivity of Plasmodium falciparum to chloroquine in pregnant women in Zaria, northern Nigeria, Trop Geogr Med, 45, 56
- Rukaria-Kaumbutho, 1996, Resistance to chloroquine therapy in pregnant women with malaria parasitemia, Int J Gynaecol Obstet, 53, 235, 10.1016/0020-7292(96)02651-3 · DOI
- Mutabingwa, 1991, Chloroquine therapy still useful in the management of malaria during pregnancy in Muheza, Tanzania, Trop Geogr Med, 43, 131
- Nosten, 2006, Antimalarial drugs in pregnancy: a review, Curr Drug Saf, 1, 1, 10.2174/157488606775252584 · DOI · Paper page
- Hart, 1964, The ototoxicity of chloroquine phosphate, Arch Otolaryngol, 80, 407, 10.1001/archotol.1964.00750040419009 · doi:10.1001/archotol.1964.00750040419009
- Paufique, 1969, Retinal degeneration in 2 children following preventive antimalarial treatment of the mother during pregnancy, Bull Soc Ophtalmol Fr, 69, 466
- Parke, 1988, Antimalarial drugs and pregnancy, Am J Med, 84, 30, 10.1016/0002-9343(88)90359-2 · doi:10.1016/0002-9343(88)90359-2
- Costedoat-Chalumeau, 2003, Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group, Arthritis Rheum, 48, 3207, 10.1002/art.11304 · DOI · Paper page
- Okanlawon, 1993, Chloroquine-induced retardation of foetal lung maturation in rats, Afr J Med Med Sci, 22, 61
- Chatterjee, 1998, Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine, Mutagenesis, 29, 10
- Munzner, 1983, Mutagenicity testing of quinine with submammalian and mammalian systems, Toxicology, 26, 173, 10.1016/0300-483X(83)90068-9 · doi:10.1016/0300-483x(83)90068-9
- Savini, 1971, Experimental study of the effects of quinine on the rat, rabbit and dog fetus, Therapie, 26, 563
- Colley, 1989, Toxicity studies with quinine hydrochloride, Toxicology, 54, 219, 10.1016/0300-483X(89)90047-4 · DOI
- Tanimura, 1972, Effects on macaque embryos of drugs reported or suspected to be teratogenic to humans, Acta Endocrinol Suppl (Copenh), 166, 293
- Lapointe, 1979, Saccharin- or quinine-induced changes in the rat pups following prolonged ingestion by the dam, Biol Neonate, 36, 273, 10.1159/000241239 · DOI
- Nosten, 1999, The effects of mefloquine treatment in pregnancy, Clin Infect Dis, 28, 808, 10.1086/515183 · DOI
- Tsuda, 1998, Detection of pyrimethamine-induced DNA damage in mouse embryo and maternal organs by the modified alkaline single cell gel electrophoresis assay, Mutat Res, 415, 69, 10.1016/S1383-5718(98)00057-6 · doi:10.1016/s1383-5718(98)00057-6
- Chung, 1993, Synergistic embryotoxicity of combination pyrimethamine and folic acid in rats, Reprod Toxicol, 7, 463, 10.1016/0890-6238(93)90091-K · doi:10.1016/0890-6238(93)90091-k
- Keuter, 1990, Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya, BMJ, 301, 466, 10.1136/bmj.301.6750.466 · DOI
- Chen, 1984, Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits, Zhongguo Yao Li Xue Bao, 5, 118
- Li, 1988, Teratogenicity of sodium artesunate, Zhong Yao Tong Bao, 13, 42
- Xu, 1996, Contragestational effects of dihydroartemisinin and artesunate, Yao Xue Xue Bao, 31, 657
- Clark, 2004, Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit, Birth Defects Res A Clin Mol Teratol, 71, 380, 10.1002/bdrb.20027 · DOI · Paper page
- White, 2004, Developmental toxicity of artesunate in the rat and rabbit, Birth Defects Res A Clin Mol Teratol, 70, 265
- Jollie, 1990, Development, morphology, and function of the yolk-sac placenta of laboratory rodents, Teratology, 41, 361, 10.1002/tera.1420410403 · DOI · Paper page
- Kawamura, 1996, Histological changes in rat embryonic blood cells as a possible mechanism for ventricular septal defects produced by an N-phenylimide herbicide, Teratology, 54, 237, 10.1002/(SICI)1096-9926(199611)54:5<237::AID-TERA4>3.0.CO;2-X · doi:10.1002/(sici)1096-9926(199611)54:5<237::aid-tera4>3.0.co;2-x
- Longo, 2006, Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro, Reprod Toxicol, 21, 83, 10.1016/j.reprotox.2005.05.005 · DOI
- Clark, 2006, Artesunate: embryolethal effects in cynomolgus monkeys, Am J Trop Med Hyg, 75, 54
- Brabin, 1993, A study of the consequences of malarial infection in pregnant women and their infants, Parasitologie, 35, 9
- Angus, 2002, Oral artesunate dose-response relationship in acute falciparum malaria, Antimicrob Agents Chemother, 46, 778, 10.1128/AAC.46.3.778-782.2002 · DOI
- Newton, 2000, Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria, Antimicrob Agents Chemother, 44, 972, 10.1128/AAC.44.4.972-977.2000 · DOI · Paper page
- Hutagalung, 2005, A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand, Malar J, 4, 46, 10.1186/1475-2875-4-46 · DOI · Paper page
- van Vugt, 1999, Absence of an interaction between artesunate and atovaquone-proguanil, Eur J Clin Pharmacol, 55, 469, 10.1007/s002280050658 · DOI
- Akintonwa, 1988, Placental and milk transfer of chloroquine in humans, Ther Drug Monit, 10, 147, 10.1097/00007691-198802000-00004 · DOI
- Massele, 1997, Chloroquine blood concentrations and malaria prophylaxis in Tanzanian women during the second and third trimesters of pregnancy, Eur J Clin Pharmacol, 52, 299, 10.1007/s002280050294 · DOI
- Chukwuani, 2004, Evidence for increased metabolism of chloroquine during the early third trimester of human pregnancy, Trop Med Int Health, 9, 601, 10.1111/j.1365-3156.2004.01227.x · doi:10.1111/j.1365-3156.2004.01227.x
- Fakeye, 2002, Therapeutic monitoring of chloroquine in pregnant women with malaria, West Afr J Med, 21, 286
- Nosten, 1990, Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study, Br J Clin Pharmacol, 30, 79, 10.1111/j.1365-2125.1990.tb03746.x · DOI
- Na Bangchang, 1994, Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria, Trans R Soc Trop Med Hyg, 88, 321, 10.1016/0035-9203(94)90101-5 · DOI · Paper page
- Phillips, 1986, Hypoglycaemia and antimalarial drugs: quinidine and release of insulin, Br J Clin Pharmacol, 21, 677, 10.1111/j.1365-2125.1986.tb05233.x · DOI · Paper page
- Wangboonskul, 1993, Single dose pharmacokinetics of proguanil and its metabolites in pregnancy, Eur J Clin Pharmacol, 44, 247, 10.1007/BF00271366 · DOI
- Alloueche, 2004, Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial, Lancet, 363, 1843, 10.1016/S0140-6736(04)16350-2 · DOI
- Brabin, 2004, Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes, Drug Saf, 27, 633, 10.2165/00002018-200427090-00002 · DOI
- Na-Bangchang, 2005, The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women, Eur J Clin Pharmacol, 61, 573, 10.1007/s00228-005-0969-7 · DOI
- Weinstein, 1976, Placental transfer of clindamycin and gentamicin in term pregnancy, Am J Obstet Gynecol, 124, 688, 10.1016/S0002-9378(16)33336-1 · DOI
- Ramsey, 2003, Maternal and transplacental pharmacokinetics of azithromycin, Am J Obstet Gynecol, 188, 714, 10.1067/mob.2003.141 · DOI
- Edwards, 2000, The management of adverse drug reactions: from diagnosis to signals, Adverse Drug Reactions J, 1, 103
- Sevene, 2005, System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe, BMJ, 331, 765, 10.1136/bmj.331.7519.765 · DOI
- Simooya, 2005, The WHO ‘Roll Back Malaria Project’: planning for adverse event monitoring in Africa, Drug Saf, 28, 277, 10.2165/00002018-200528040-00001 · DOI
- Taylor, 2004, Antimalarial drug toxicity: a review, Drug Saf, 27, 25, 10.2165/00002018-200427010-00003 · DOI · Paper page
- Edwards, 1998, Safety monitoring of new anti-malarials in immediate post-marketing phase, Med Trop (Mars), 58, 93
- Dodoo, 2005, Effectiveness of a simplified spontaneous reporting form for intensive monitoring of adverse events during intermittent preventive treatment of malaria in pregnant women with sulphadoxine-pyrimethamine, Drug Saf, 28, 958
- Dodoo, 2005, Preliminary safety assessment of sulphadoxine-pyrimethamine during intermittent presumptive treatment of pregnant women in a region with high prevalence of G6PD deficiency, Int J Risk Saf Med, 17, 13, 10.3233/JRS-2005-329 · doi:10.3233/jrs-2005-329
- Beyens, 2003, Prescription of drugs to pregnant women in France: the HIMAGE study, Therapie, 58, 505, 10.2515/therapie:2003082 · DOI
- Gomes, 1999, Prevalence of use of medicines during pregnancy and its relationship to maternal factors, Rev Saude Publica, 33, 246, 10.1590/S0034-89101999000300005 · doi:10.1590/s0034-89101999000300005
Cited by
Reducing the burden of malaria in pregnancy by preventive strategies
Menéndez, C., D'Alessandro, U., & ter Kuile, F. O. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70024-5 · Cited by 188
McGready, R., Tan, S. O., Ashley, E. A., Pimanpanarak, M., Viladpai-nguen, J., Phaiphun, L., Wüstefeld, K., Barends, M., Laochan, N., Keereecharoen, L., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050253 · Cited by 136
“]. There is increasing evidence that the pharmacokinetic properties of several antimalarial drugs, including artemisinin derivatives, are affected significantly in late pregnancy resulting in lower blood concentrations. In the study area, current first-line treatment for falciparum malaria in pregnancy is quinine and…”
BackgroundSelf-citationManyando, C., Mkandawire, R., Puma, L., Sinkala, M., Mpabalwani, E., Njunju, E., Gomes, M., Ribeiro, I., Walter, V., Virtanen, M., et al. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-249 · Cited by 67
Clerk, C. A., Bruce, J., Affipunguh, P. K., Mensah, N., Hodgson, A., Greenwood, B., & Chandramohan, D. (2008) · The Journal of Infectious Diseases · doi:10.1086/591944 · Cited by 65
Schlagenhauf, P., Blumentals, W. A., Suter, P., Regep, L., Vital-Durand, G., Schaerer, M. T., Boutros, M. S., Rhein, H.-G., & Adamcova, M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis215 · Cited by 57
“Thus, for ethical, safety, and logistical reasons, there is a lack of data on the use of antimalarials by pregnant women [13].”
Background
Metadata
- Authors
- Ward, S. A., Sevene, E. J., Hastings, I. M., Nosten, F., & McGready, R.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 136-144
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W1987142506
- Cited by
- 159
- References
- 7
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. https://app.cochat.ai/papers/10.1016/s1473-3099(07)70025-7
- The paper
- Ward, S. A., Sevene, E. J., Hastings, I. M., Nosten, F., & McGready, R. (2007). Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(07)70025-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.